Throw out the fax machines: The cancer world needs to modernize molecular test reporting
At MedCity’s CONVERGE conference July 31-August 1 in Philadelphia next week, I’m speaking on some of the challenges that are holding back precision medicine.
Jon Hirsch
Jonathan Hirsch is Founder and President of Syapse, a precision oncology company. He is also Chair of the Data Committee for GBM AGILE, a global initiative to find a cure for brain cancer, and served on the White House Cancer Moonshot Data Sharing Working Group.